PD-L1 Immunotherapy Tests

PD-L1 Immunotherapy Tests

PD-L1 immunotherapy tests evaluate the expression of the PD-L1 protein on cancer cells, helping determine eligibility for PD-L1 inhibitors. PD-L1 immunotherapy tests are critical for identifying patients likely to benefit from immune checkpoint inhibitors, particularly in cancers like non-small cell lung cancer. These tests guide personalised treatment plans in oncology.